Danazol: An antigonadotropic agent in the treatment of pelvic endometriosis
article
OA: closed
CC0
⤵ 50 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper investigated danazol, an antigonadotropic agent, for its efficacy in treating pelvic endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (7)
- Clinical Studies with an Antigonadotropin-Danazol via openalex
- Danazol—a Synthetic Steroid Derivative with Interesting Physiologic Properties via openalex
- Experiences with Danazol (an antigonadotropin) in the treatment of infertility via openalex
- Oral Contraceptive Activity of Danazol in the Rhesus Monkey via openalex
- Pituitary and Testicular Function Studies. I. Experience with a New Gonadal Inhibitor, 17α-Pregn-4-en-20-yno-(2,3-d) isoxazol-17-ol (Danazol)<sup>1</sup> via openalex
- Pituitary Gonadotropin Inhibitory Activity of Danazol via openalex
- The treatment of endometriosis with Danazol. via openalex
Cited by (50)
- Danazol 2022
- Danazol alters mitochondria metabolism of fibrocystic breast Mcf10A cells 2017
- Medical Treatment of Ureteral Obstruction Associated With Ovarian Remnants and/or Endometriosis: Report of Three Cases and Review of the Literature 2014
- Current diagnostic and treatment strategies for adenomyosis 2006
- Ureteral Endometriosis 2003
- Adenomyosis 2003
- Medical and Surgical Therapies for Pain Associated with Endometriosis 2001
- Preventive effects of danazol on endometrial carcinogenesis in mice 2000
- Effects of dienogest (a synthetic steroid) on coagulation, fibrinolysis, and platelet aggregation in female monkeys 1998
- Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate 1990
- Endometriosis 1990
- GnRH Analogues in the Treatment of Endometriosis 1989
- Adenomyosis: a retrospective view. 1989
- Danazol in the Treatment of Ureteral Endometriosis 1988
- Placebo-controlled comparison of danazol and high-dose medroxypro-gesterone acetate in the treatment of endometriosis after conservative surgery 1987
- Endometriosis 1987
- Catamenial Pneumomediastinum 1986
- Treatment of Pelvic Endometriosis with Gestrinone ‐Report on 9 Cases ‐ 1985
- Management of pelvic endometriosis with low-dose danazol 1985
- Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up 1985
- Postoperative danazol therapy in infertility patients with severe endometriosis 1985
- Endometriosis of the sigmoid colon 1984
- Short‐term effects of danazol on endometrial histology 1984
- Endometriosis 1984
- Endometriosis and infertility 1984
- THE INTERACTION OF HUMAN ENDOMETRIAL AND MYOMETRIAL STEROID RECEPTORS WITH DANAZOL 1983
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. 1983
- Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesterone 1982
- Danazol 1982
- Effects of danazol on gonadal steroidogenesis in patients with a complete form of testicular feminization 1982
- Hormonal and Surgical Management of Pelvic Endometriosis 1982
- Catamenial Pneumothorax in Sisters 1981
- Management of Pelvic Endometriosis with Low-Dose Danazol 1981
- Androgen uptake in the female reproductive system of a nonhuman primate 1981
- Transient Adrenogenital Syndrome due to Exposure to Danazol in Utero 1981
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness 1981
- Danazol inhibits human adrenal 21-and 11β-hydroxylation invitro 1980
- Hypertension: a complication of danazol therapy 1980
- Evidence that danazol inhibits gonadotropin-induced ovarian steroidogenesis at a point distal to gonadotropin-receptor interaction and adenosine 3′,5′ cyclic monophosphate formation 1980
- Review: The Mechanism of Action of Danazol, a Novel Steroid Derivative 1980
- Danazol in the Treatment of Endometriosis 1980
- Effect of danazol on estradiol-17β and progesterone secretion by porcine ovarian cells in vitro 1979
- The “Treatment” of Unexplained Infertility with Danazol 1979
- Danazol Binding to Rat Androgen, Glucocorticoid, Progesterone, and Estrogen Receptors: Correlation With Biologic Activity 1979
- Danazol Administration to Females with Menses-Associated Exacerbations of Acute Intermittent Porphyria 1979
- The Surgical Treatment of Endometriosis 1978
- ENDOMETRIOSIS OF THE SIGMOID COLON AND RECTUM 1978
- Fertility in the Rhesus Monkey Following Long-Term Inhibition of Ovarian Function with Danazol 1978
- Danazol Inhibits Steroidogenesis 1977
- DANAZOL: AN ANTIGONADOTROPHIC AGENT IN THE TREATMENT OF RECURRENT PELVIC AND INTESTINAL ENDOMETRIOSIS 1977
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-14T05:58:58.463083+00:00
- unpaywall
- last seen: 2026-06-15T06:18:04.506796+00:00
License: CC0
· commercial use OK